Because ASM is a stress-amplifier enzyme. Suppressing it can be good when the ASM → ceramide system is overactive and turning normal stress into inflammation, apoptosis, insulin resistance, membrane damage, or immune overreaction. Tiny enzyme, giant biological tantrum. 
But it is not universally good. Full ASM loss is bad. Partial/contextual suppression can be useful.
The core idea
ASM does this:
sphingomyelin --ASM--> ceramide + phosphocholine
Ceramide is not just a fat blob. It is a bioactive membrane signal. When ASM gets activated by stress, inflammation, oxidative injury, infection, radiation, TNF-alpha, etc., it rapidly generates ceramide in membranes and lysosomal/endosomal compartments.
That ceramide can form ceramide-rich membrane platforms, which cluster receptors and signaling proteins. This makes cells respond more strongly to stress, apoptosis, cytokines, pathogens, and inflammatory cues. ASM-generated ceramide is specifically described as shaping membrane structure and signal transduction, especially in macrophage/immune contexts. (PMC)
So the crude model is:
stress → ASM activation → ceramide platforms → amplified stress signaling
Suppress ASM and you blunt that amplification:
ASM suppression
→ less stress-induced ceramide
→ less receptor clustering / death signaling / inflammatory amplification
→ more cellular resilience in some contexts
Why that can be “longevity-good”
1. Less pathological ceramide signaling
Ceramide often rises in metabolic stress, lipotoxicity, inflammation, and aging-adjacent disease states. Reviews link ceramides to insulin resistance, diabetes complications, cardiovascular disease, and broader metabolic dysfunction. (PMC)
Mechanistically, ceramide can interfere with insulin signaling, mitochondrial function, Akt signaling, inflammatory signaling, and cell survival. So suppressing one source of ceramide, especially stress-induced ASM-derived ceramide, can look protective.
The “good” version:
↓ ASM-derived ceramide
→ ↓ lipotoxic signaling
→ ↑ insulin/Akt pathway sanity
→ ↓ inflammatory apoptosis
→ better stress tolerance
Not because ceramide is evil. Because excess or misplaced ceramide is a cellular alarm bell that sometimes gets stuck on.
2. Less apoptosis / death-receptor amplification
Ceramide-rich domains can cluster receptors involved in death signaling. ASM activation is often downstream of stressors like TNF-alpha, Fas/CD95, radiation, oxidative stress, and infection-like signals. In that mode, ASM is like a bouncer who panics and starts punching the furniture.
Suppressing ASM can reduce:
death receptor clustering
mitochondrial stress
caspase activation tendency
inflammatory cell death
That is one reason ASM inhibitors look protective in some inflammatory, neurodegenerative, pulmonary, and metabolic models. Reviews describe the ASM/ceramide pathway as a therapeutic target across metabolic and inflammatory disease contexts. (PMC)
3. Less inflammatory immune overreaction
Macrophages use ASM/ceramide signaling for membrane remodeling, cytokine responses, pathogen handling, cholesterol trafficking, and inflammatory activation. Useful in moderation, bad when chronically overactive. (PMC)
In chronic disease, aging, obesity, diabetes, lung disease, and vascular disease, the problem is often not “immune system too weak.” It is “immune system stuck in a deranged low-grade smoke alarm state,” because apparently cells also enjoy Slack notifications.
So ASM suppression can reduce inflammatory amplification:
↓ ASM
→ ↓ ceramide-rich platforms
→ ↓ exaggerated cytokine/receptor signaling
→ ↓ chronic inflammatory tone
4. It may mimic a stress-resistance switch in simple organisms
In C. elegans, acid sphingomyelinase inhibition is directly longevity-relevant. The worm ASM gene asm-3 acts as a positive regulator of the insulin/IGF-like pathway, and reducing ASM activity extended lifespan through DAF-16/FOXO. Desipramine and clomipramine, both ASM-inhibiting drugs, extended lifespan in that model. (PubMed)
That implies:
ASM suppression
→ less insulin/IGF-like pro-growth tone
→ more DAF-16/FOXO stress-resistance activity
→ longer worm lifespan
Worms are not humans, tragically or thankfully, depending on your opinion of worms. But the pathway logic is interesting: ASM suppression may push cells away from growth/stress-amplification and toward maintenance/stress resistance.
5. Possible autophagy / ULK1 angle
ASM suppression can alter lysosomal sphingomyelin/ceramide balance, and that can affect nutrient sensing, mTORC1, PP2A, AMPK, and ULK1.
The good version:
mild ASM suppression
→ altered lysosomal lipid state
→ lower mTORC1 restraint or PP2A/AMPK effects
→ ULK1 activation
→ autophagy initiation
But the bad version is very real:
too much lysosomal disruption
→ sphingomyelin/phospholipid accumulation
→ impaired lysosomal degradation
→ autophagy traffic jam
So when people say “ASM inhibition activates autophagy,” squint at them suspiciously and ask whether they measured flux, not just LC3-II confetti.
Why complete ASM suppression is bad
This is the giant caveat with flashing lights and a little siren.
Inherited ASM deficiency causes acid sphingomyelinase deficiency / Niemann-Pick disease types A/B, a lysosomal storage disease where sphingomyelin accumulates in lysosomes, especially in macrophages and organs. (NCBI) Severe ASM deficiency can cause neurodegeneration, hepatosplenomegaly, lung disease, cytopenias, and lysosomal dysfunction. (SpringerLink)
So:
partial/transient ASM suppression = potentially protective in overactive ASM states
complete/chronic ASM loss = sphingomyelin storage disease
This is the hormetic-looking zone:
too much ASM → ceramide stress toxicity
too little ASM → sphingomyelin storage / lysosomal dysfunction
middle modulation → maybe useful
Biology, being petty, almost always has a U-shaped curve.
The best one-sentence answer
ASM suppression is “good” when it reduces excess stress-induced ceramide signaling: less inflammatory amplification, less apoptosis/death-receptor clustering, less metabolic lipotoxicity, and possibly more FOXO/autophagy/stress-resistance tone.
But it is only good as partial contextual suppression, not as “delete ASM.” Full ASM deficiency causes sphingomyelin buildup and lysosomal disease. The trick is turning down the smoke alarm, not ripping it out of the ceiling and declaring victory while the kitchen burns.